| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |